SutroVax raises $22 million in Series A

SutroVax raises $22 million in Series A Press release published by SutroVax, Vaccine Spin-off from Sutro Biopharma to Utilize Site-Specific Conjugation Technology Read more Vaccine Spin-off from Sutro Biopharma to Utilize Site-Specific Conjugation Technology South San...